Immunotherapy Experts Gather In New York As Innate Pharma Hosts KOL Scientific Symposium On 3rd October, 2024

Innate Pharma is partnering with the Icahn School of Medicine at Mount Sinai to host a scientific symposium called "Next Generation Immunotherapy Discoveries." The symposium is scheduled for Thursday, October 3, 2024, from 10:00 a.m. to 5:30 p.m. EDT, and will take place both in-person at the Hess Center for Science and Medicine in New York City and virtually online.

As part of Innate Pharma's 25th anniversary celebrations, this prominent scientific event will showcase cutting-edge developments in immunotherapy. Renowned experts in the field will present their insights, followed by interactive Q&A sessions where participants can engage directly with the speakers.

Hervé Brailly, Chief Executive Officer at Innate Pharma, commented, “Since its inception in 1999, Innate Pharma has been pioneering immuno-oncology, which has revolutionised cancer care. As we celebrate 25 years of innovation at Innate Pharma, this is an opportunity to look forward, not only at the broad and diversified pipeline that Innate has generated but beyond at the next frontiers of immunotherapy. Leading scientists and clinicians will share their perspectives at the Next Generation Immunotherapy Discoveries symposium in New York on October 3rd. We thank Mount Sinai Hospital for hosting this exciting event.”